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Background: Phosphoinositide 3-kinases (PI 3-kinases)
are thought to play an important role in coordinating the
responses elicited by a variety of growth factors, onco-
gene products and inflammatory stimuli. These responses
include activation of membrane ruffling, chemotaxis, glu-
cose transport, superoxide production, neurite outgrowth
and pp70 S6 kinase. Some of these responses are also
known to be regulated by Rac, a small GTP-binding
protein related to Ras. Neither the transducing elements
upstream of Rac, nor those downstream of PI 3-kinase,
have been defined.
Results: We show here that platelet-derived growth
factor (PDGF) can stimulate an increase in the level of
GTP-Rac by at least two distinct mechanisms: firstly, by
increased guanine nucleotide exchange; and secondly, by
inhibition of a Rac GTPase activity. The first of these
mechanisms is essential for the activation of Rac, and
we show that it is dependent upon PDGF-stimulated
synthesis of phosphatidylinositol (3,4,5)-trisphosphate.
Conclusions: These results suggest that Rac activation
lies downstream of PI 3-kinase activation on a PDGF-
stimulated signalling pathway. Furthermore, as Rac has
been implicated in at least two diverse ellular responses
that are also thought to require activation of PI 3-kinase -
a reorganization of the actin cytoskeleton known as mem-
brane ruffling and the neutrophil oxidative burst - these
results suggest that Rac may be a major effector protein for
the PI 3-kinase signalling pathway in many cell types.
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Background
Phosphoinositide 3-kinases (PI 3-kinases) catalyze the
phosphorylation of the membrane phospholipid phos-
phatidylinositol (4,5)-bisphosphate (Ptdlns(4,5)-P 2) to
yield Ptdlns(3,4,5)-P 3, and are activated acutely by a
variety of cell-surface growth-factor receptors, Src-type
tyrosine kinases and certain G-protein-coupled receptors
[1,2]. The characteristics of this response have led to the
suggestion that Ptdlns(3,4,5)-P 3 may be a new second
messenger [3-5]. Recently, a number of diverse cell
responses have been proposed to depend upon recep-
tor-stimulated synthesis of this phospholipid [6-14], but
its direct intracellular target is still unknown and very lit-
tle is currently understood of the molecular interactions
that occur downstream in this pathway.
The isoform of PI 3-kinase that is known to be regulated
by protein tyrosine kinases is a heterodimer composed of
a tightly bound 85 kD regulatory [15-17] subunit (p85),
containing two Src-homology region 2 (SH2) domains,
and a 110 kD catalytic [18] subunit. The SH2 domains
in p85 can bind tightly to phosphotyrosines within spe-
cific local sequences [1,19,20], leading to the activation
of PI 3-kinase [21,22]. Many of these phosphorylated
tyrosines - residues 740 and 751 of the platelet-derived
growth factor (PGDF) 13-receptor, for example - are
autophosphorylation sites in receptor protein tyrosine
kinases; thus, these receptors can simultaneously recruit
and activate PI 3-kinase.
Four different approaches have been employed to inhibit
the activation of PI 3-kinase. First, the deletion of the
specific phosphotyrosines to which the p85 subunit binds
[19,20]. Second, the use of small phosphopeptides that
mimic the phosphotyrosine residues to which p85 binds
[7], which act as competitive inhibitors of the endoge-
nous activation mechanisms. Third, overexpression of a
p85 deletion mutant (Ap85) that lacks a pl10 binding
site, but is still able to associate specifically with appropri-
ate phosphotyrosines [6,10]; this mutant can, therefore,
compete with endogenous PI 3-kinase for upstream acti-
vators. Fourth, the fungal metabolite wortmannin has
been shown to bind to, and inhibit the activity of, the
catalytic subunit of PI 3-kinase [12,23,24].
Each of these strategies has been used to define a role for
PI 3-kinase activation in the growth-factor induced reor-
ganization of the actin cytoskeleton that is manifested in
the formation of lamellipodia and ruffles [6,7]. A similar
rearrangement of actin filaments had previously been
shown to occur in response to the microinjection of a
constitutively active form of the small GTP-binding pro-
tein Rac [25]. These observations, together with other
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circumstantial evidence, led to the suggestion that the
effects of PI 3-kinase activation are mediated via Rac [6].
We have sought to establish whether Rac is activated
by PDGF, and whether this response requires PI 3-
kinase-catalyzed synthesis of Ptdlns(3,4,5)-P 3.
Results
PI 3-kinase acts upstream of Rac in PDGF-stimulated
lamellipodia formation
Expression vectors containing the cDNA for V12 Rac-1,
a constitutively active mutant of Rac [26], N17 Rac-1, a
potentially dominant negative form of Rac [25], or Ap85,
were injected into porcine aortic endothelial (PAE) cells
stably expressing either the wild-type human PDGF
[3-receptor (PDGFR3-PAE cells, [8]) or PDGF 13 recep-
tors in which tyrosines at positions 740 and 751 are
replaced with phenylalanine residues (Y740/751F-
PDGFRP-PAE cells, [8]). Wortmannin, Ap85 and N17
Rac-1 each caused a dramatic inhibition of PDGF-stimu-
lated lamellipodia formation in PDGFRP3-PAE cells (Fig.
1). PDGF was unable to activate PI 3-kinase [6] or lamel-
lipodia formation in Y740/751F- PDGFR3-PAE cells
(Fig. 1). Expression of V12 Rac-1 caused extensive lamel-
lipodia formation in both cell lines, an effect that was
insensitive to wortmannin or expression of Ap85 (Fig. 1).
These results confirm earlier work implicating both Rac
and PI 3-kinase in the mechanism by which PDGF stim-
ulates lamellipodia formation [6,25]. However, they addi-
tionally suggest that Rac must either act downstream of,
or be on a distinct pathway from, PI 3-kinase.
A PDGFRI3-PAE clone expressing epitope-tagged Rac-1
A major problem in measuring the activation of Rac in
vivo has been the lack of available reagents that can be
used to isolate Rac with its native complement of GTP
preserved (for example, antibodies equivalent to those
used to assay activation of Ras [27]). We have attempted
to circumvent this problem by deriving a number of
stable, clonal PAE cell lines overexpressing an epitope
-tagged form of Rac-1, Rac-l(EE) [28]. The levels of
Rac-l(EE) we obtained in such cell lines were between
10-100-fold greater than that of endogenous Rac. These
cell lines displayed a range of levels of lamellipodia for-
mation, even in confluent and/or serum-starved condi-
tions, that correlated with the extent to which they
expressed Rac-l(EE) (data not shown). Even in cells
expressing the lowest amounts of Rac-l(EE), roughly
60 % of the Rac- 1 (EE) was recovered in membrane frac-
tions. In contrast, less than 5 % of total Rac-1 in the
parental cell line was in this fraction (Fig. 2a).
As membrane localization has been implicated in the
activation of Rac-2 in neutrophils [29,30], the phenotype
and subcellular localization of Rac-l(EE) suggest it is at
least partially active in these. cells. Consequently, two
clones of PDGFR3-PAE cells expressing the least
Rac-l(EE) - PDGFR13-PAE-49 and PDGFR3-
PAE-144 cells - were selected for further study. In
PDGFR13-PAE-49 cells, PDGF stimulated an increase in
the proportion of cells displaying lamellipodia, in the
number of lamellipodia per cell, and in the appearance of
circular ruffles (a phenotype previously seen in wild-type
cells, possibly correlated with supra-stimulation with
agonists). All of these effects were inhibited by the addi-
tion of wortmannin (Fig. 2b and legend).
Fig. 1. V12 Rac-1 overrides the inhibition of PI 3-kinase in
PDGF-induced lamellipodia formation. PDGFR[3-PAE cells and
Y740/751F-PDGFR-PAE cells were grown on cover slips and
injected with expression plasmids for Ap85, myc-tagged N17
Rac-1 and/or myc-tagged V12 Rac-1. The cells were
serum-starved for 12 hrs, challenged with wortmannin or vehicle
for 10 min and then PDGF for 2 mins. The cells were fixed, and
injected cells identified by measuring anti-Myc and anti-p85
immunofluorescence; lamellipodia/ruffling was visualized by
staining in parallel with FITC phalloidin. Lamellipodia formation
in PDGFR[3-PAE cells (grey bars) and in Y740/751F-PDGFR[3-
PAE cells (white bars) is shown under the various conditions.
PDGF-stimulated increase in the GTP content of Rac-1 (EE)
in intact PDGFR3-PAE-49 cells
More than 70 % of the total Rac-1(EE) could be im-
munoprecipitated from a detergent lysate of PDGFR3
-PAE-49 cells (data not shown), with an -60 % recovery
of both its total guanine nucleotide content and the
initial proportion of GTP bound. The value of 60 % was
derived by comparison with baculovirus-expressed
Rac-l(EE), preloaded in vitro with 0o[32 P]GTP and
immunoprecipitated in the presence of an equivalent
lysate of PDGFR,3-PAE cells (data not shown).
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Fig. 2. Characterization of PDGFRiP-
PAE-49 cells. (a) Western blots of
cytosol and membrane fractions pre-
pared from wild-type PDGFRI-PAE
cells and PDGFR[3-PAE-49 cells using
either anti-Rac-l or anti-EE antibodies.
Membrane and cytosol fractions were
prepared from wild-type PDGFR-PAE
and PDGFRI3-PAE-49 cells by sonica-
tion followed by centrifugation on
sucrose gradients [29]. Equivalent
amounts of protein from both cell types
were western blotted and probed with
either an anti-Rac-1 peptide polyclonal
serum or with an epitope tag (EE)
specific monoclonal antibody. The
anti-Rac-l immunoreactive band in
PDGFRI3-PAE cells and PDGFRI3-
PAE-49 cells that migrates below Rac-1
was, in contrast to Rac-1, unchanged by
transient expression of Rac-1 (EE) and is
therefore probably irrelevant. (b)
Fluorescence micrographs of FITC-phal-
loidin stained wild-type PDGFR-PAE
cells and PDGFR[3-PAE-49 cells chal-
lenged with either PDGF or vehicle.
PDGFRP-PAE-49 cells or wild-type
PDGFRO3-PAE cells were grown on glass
cover slips, serum-starved (16 hrs;
Ham's F12 medium, 0.1 % BSA), chal-
lenged with either PDGF[3 (75 ng ml-1 )
or vehicle for 4 mins, and then fixed
and processed to visualize actin fila-
ments using FITC-labelled phalloidin as
described previously [6]. The proportion
of PDGFRP-PAE-49 cells showing edge
ruffling (arrow marked E) or circular ruf-
fles (arrow marked C) rose from 31 %
(n=254) to 84% (n=169) or 0 % to
21 %, respectively, upon stimulation
with PDGF. Both of these responses
were inhibited by 10 min pretreatment
with 100 nM wortmannin - to 36 %
and 1% (n=102), respectively - al-
though wortmannin did not significantly
reduce the proportion of control cells
displaying either of these phenotypes -
30 % and 0 % (n=174), respectively.
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PDGF stimulated a small (-1.7-fold), but highly signifi-
cant, increase in the [32 P]GTP content of Rac-1(EE)
immunoprecipitated from [3 2 P]Pi-prelabelled PDGFRP-
PAE-49 and PDGFR[-PAE-144 cells (Figs 3a and 3b).
This response was inhibited by pretreatment of the cells
with 100 nM wortmannin (Fig. 3b).
PDGF-stimulated increase in the GTP content of Rac-1(EE)
in permeabilized PDGFRJ3-PAE-49 cells
The mechanisms underlying the PDGF-stimulated in-
crease in the GTP-Rac:GDP-Rac ratio were analyzed
further by assaying the incorporation of [32 p] from
o[ 32P]GTP into GTP-Rac and GDP-Rac in strepto-
lysin-O permeabilized PDGFRI-PAE-49 cells. When
PDGF was added simultaneously with ot[32 P]GTP, the
accumulation of [3 2 P]GTP-Rac-1 (EE) was accelerated
approximately three-fold (Fig. 4a). This response to
PDGF was a result of the combined effect of a PDGF-
stimulated increase in the incorporation of total [32 p]
into Rac-1(EE), particularly at earlier times of stimula-
tion (Fig. 4b), and a PDGF-stimulated increase in
the [3 2 P]GTP-Rac:[ 32 P]GDP-Rac ratio recovered in
Rac-1(EE) (Fig. 4c).
The rate of accumulation of total [3 2 P]Rac-1(EE) in
these experiments is a measure of the rate of exchange of
guanine nucleotide on Rac. The PDGF-stimulated accu-
mulation of total [3 2 P]Rac-l(EE) was abolished in the
presence of wortmannin (Fig. 5b; two minutes), and
partially inhibited (by -66 %) by a doubly tyrosine phos-
phorylated peptide (Y-PP) based on the 20 amino-acid
sequence surrounding tyrosines 740 and 751 of the
human PDGF 3-receptor (Fig. 5d). In parallel assays,
wortmannin and Y-PP inhibited PDGF-stimulated
Ptdlns(3,4,5)-P 3 synthesis by 80 % and 67 %, respectively
(Fig. 6). Thus, PDGF stimulates the rate of guanine nu-
cleotide exchange on Rac, via a mechanism that depends
on PI 3-kinase-catalysed synthesis of Ptdlns(3,4,5)-P 3.
Fig. 3. Measurement of the [3 2p] guanine nucleotide content of
Rac-I(EE) in [3 2P1Pi-labelled PDGFRi3-PAE-49 cells. (a) Thin
layer chromatography (TLC) separation of the [3 2p] guanine
nucleotides present on Rac-1(EE) immunoprecipitated from
[32P]Pi-labelled PDGFRP-PAE-49 incubated with (+) or without
(-) PDGF (three replicate samples are shown for each condition).
(b) The ratio of [32P]GTP/[32 P]GDP recovered on Rac-1(EE) im-
munoprecipitated from [32P]P-labelled PDGFRI-PAE-49 cells in-
cubated with or without PDGF, in the presence or absence of
wortmannin, as indicated. The data shown are means +SEM
(n=3). The difference between control and PDGF was significant
(p<0.001); the difference between control and PDGF, wortman-
nin was not significant (p<0.2); the difference between control
and control, wortmannin was not significant (p<0.4). The total
amount of 32p recovered in the formic acid supernatants prior to
TLC were (mean + SEM (dpm)): control, 17620+ 1963; PDGF,
17096 +± 5084; control, wortmannin 19502 +± 2468; PDGF, wort-
mannin, 16644 + 1648. Similar data were obtained in three fur-
ther experiments with PDGFR-PAE-49 cells and in one
experiment with PDGFR-PAE-144 cells.
The PDGF-stimulated increase in ratio of [32P]GTP:
[3 2P]GDP recovered on Rac-1(EE) after five minutes
stimulation was substantially resistant to the presence of
100 nM wortmannin (Fig. 5c). Hence, in the presence
of wortmannin, there was a change in the ratio of GTP:
GDP recovered on Rac-1(EE), without a detectable
alteration in overall exchange (Fig. 5b), indicating that
PDGF had caused an inhibition of GTP hydrolysis on
Rac-1(EE), and that this effect of PDGF was indepen-
dent of PDGF-stimulated synthesis of Ptdlns(3,4,5)-P 3.
Wortmannin caused a much greater inhibition of
PDGF-stimulated [3 2 P]GTP-Rac accumulation after a
two minute stimulation (-90 % inhibition; Fig. 5a) than
after a five minute stimulation (-40 % inhibition; Fig.
5a). This is because the effect of PDGF on [3 2 P]GTP-
Rac accumulation is dominated by stimulation of gua-
nine-nucleotide exchange at earlier times, but by an
inhibition of Rac-GTP hydrolysis at later times (Fig. 5b
versus Fig. 5c). It is difficult to predict how the relative
magnitudes of the two effects that we have measured
in permeabilized cells relate to the situation in PDGF-
stimulated intact cells, but it is clear that wortmannin
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Fig. 4. Measurement of the [32PIGTP: 32P]GDP content of
Rac-(EE) in permeabilized PDGFR[-PAE-49 cells. Cells were
permeabilized with streptolysin-O for 2 min before addition of
a[3 2PIGTP and either PDGF () or its vehicle (). At the indi-
cated times, Rac-I(EE) was immunoprecipitated and an estimate
made of its guanine nucleotide content. All values are means
+ SEM (n=4). Where no error bars are shown they fall within the
symbols. 250 arbitrary units of radioactivity as measured by the
phosphoimager is equivalent to -10 000 dpm for this set of data.
(a) Accumulation of 32PIGTP-Rac-1(EE). In the presence of
PDGF, values were significantly higher than controls; p<0.01 for
the 1 and 2 min data, and p<0.02 for the 6 min data. (b)
Accumulation of [32P]GTP-Rac-1(EE) + [32P]GDP-Rac-1(EE).
Values in the presence of PDGF were significantly higher than
controls; p<0.001 for the 1 and 2 min data and p<0.1 for the
6 min data. (c) Ratio of [32P]GTP:([32P]GTP + [32P]GDP) in Rac-
1(EE). Values in the presence of PDGF were significantly higher
than controls; p<0.02, p<0.05 and p<0.01 for the 1 min, 2 min
and 5 min data respectively. (d) TLC separation of [3 2p] guanine
nucleotides recovered on Rac-I(EE) after 2 min in the presence
(+) or absence of (-) of PDGF (four replicate samples are shown
for each condition).
Discussion
G proteins are a large family of molecules involved in a
huge variety of pathways, in which they serve as critical
integrating transducers capable of delivering an on/off
signal [31]. These proteins exist in either GDP- or GTP-
bound forms, and cycle between them as a function of
their intrinsic capacity to exchange free guanine nucleo-
tide and to hydrolyze bound GTP to GDP. However,
only the GTP-bound form is recognized by effector
proteins (this being the 'on' form).
Experiments carried out using site-directed mutants of
Rac have helped to implicate Rac in growth-factor stim-
ulated membrane ruffling [25], and suggest that the
GTP-bound form of Rac is indeed the likely effector
conformation of this protein. Of these mutants, N17 Rac
is analogous to a dominant negative mutant of Ras, and
is envisaged to remain in a GDP-bound or nucleo-
tide-free state, but to compete with wild-type Rac for a
common pool of activating proteins. On the other hand,
V12 Rac, which is analogous to a constitutively active
mutant of Ras, has a reduced intrinsic GTPase activity
and is thus believed to exist predominantly in the
GTP-bound state. Our observation that PDGF stimulates
an increase in the GTP content of Rac-1(EE) in
PDGFR,3-PAE-49 cells, and that this response is inhib-
ited by manipulations of PI 3-kinase activation -
manipulations which also inhibit lamellipodia outgrowth,
a downstream response to Rac-activation - strongly
support this view.
The on/off (GTP/GDP) cycles of different G proteins are
regulated in different ways. In the case of Ras proteins,
two types of regulatory protein interact directly with the
core G-proteins. Guanine nucleotide exchanger proteins
(GEXs) accelerate nucleotide exchange and thus can, in
has a very substantial potential to inhibit formation of the context of the high GTP:GDP ratio maintained in the
Rac-GTP and, therefore, any downstream response cytosol, result in G-protein activation. GTPase activation
which is dependent upon it. proteins (GAPs) accelerate the rate of hydrolysis of bound
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GTP, and thus can cause G-protein inactivation [31].
Growth factor and antigen receptors have been shown to
stimulate Ras via activation of specific GEXs [31,32]
and/or inhibition of specific GAPs [27,31]. Similar pro-
teins may interact with Rac and thus drive the increase
in GTP-Rac that we have measured. Indeed, several
Rac-GAPs - for example, Bcr, n-chimaerin, Rho GAP,
p190 and the p85 subunit of PI 3-kinase [33-35] - have
been defined either on the basis of their activities in vitro,
or their homology to characterized proteins. But there is
no evidence specifically implicating any of these proteins
in growth-factor activation of Rac.
Inhibition of a putative Rac-GAP is the simplest explana-
tion for the PDGF-stimulated, wortmannin-resistant
increase in the GTP:GDP ratio recovered on Rac-1(EE)
from permeabilized cells. It is uncertain, however, what
type of activity may be responsible for the wortman-
nin-sensitive increase in guanine nucleotide exchange on
Rac. This is because Rac, unlike Ras, is known to inter-
act with a 'guanine nucleotide dissociation inhibitor' that
can also bind to Rho proteins - generally referred to as
RhoGDI. RhoGDI is thought to hold Rac in a GDP-
bound state in the cytosol and may prevent its interaction
with putative GEXs [36-40]. In principle, it would seem
that the RhoGDI-Rac complex could dissociate before,
during, or after guanine nucleotide exchange on Rac.
Furthermore, there are precedents, from recent studies of
the regulation of Rab proteins and heterotrimeric G pro-
teins, which suggest that either of the first two possibilities
are highly plausible (Fig. 7 and legend).
Fig. 5. Effects of wortmannin or Y-PP on the guanine nucleotide
content of Rac-1(EE) in permeabilized PDGFR[ PAE-49 cells.
(a-c) Effect of wortmannin on PDGF-stimulated changes in the
guanine nucleotide content of Rac-1(EE). Cells were permea-
bilized for 2 min then incubated with oa32P]GTP and either
PDGF (hatched bars) or its vehicle (open bars) for a further
2 min or 5 min. All incubations were carried out in the pres-
ence of either 100 nM wortmannin or its vehicle as indicated.
Values are means + SEM (n=6 for 2 min data; n=8 for 5 min
data). 250 arbitrary units of radioactivity is equivalent to
approximately 5000 dpm. Two further experiments have been
carried out with similar results. (a) Accumulation of
[32P]GTP-Rac-1 (EE). (b) Accumulation of [32P]GTP-Rac-1 (EE) +
[32P]GDP-Rac-1(EE). In the absence of wortmannin, values for
PDGF were significantly higher than control, p<0.01 and
p<0.001 for the 2 min and 5 min data, respectively: in the pres-
ence of wortmannin, the PDGF values were not significantly
different from the control values at either time. (c) Ratio of
[32P]GTP-Rac-1/([ 32 p]GDP + 32 P]GTP)>in Rac-1(EE). In the
absence of wortmannin, values for PDGF were significantly
higher than control, p<0.001 and p<0.001 for the 2 min and
5 min data, respectively; in the presence of wortmannin, the
values for PDGF were also significantly higher than control,
p<0.005 and p<0.001 for the 2 min and 5 min data, respec-
tively. (d) Effect of Y-PP on PDGF-stimulated guanine
nucleotide exchange on Rac-1(EE). Cells were permeabilized
for 3 min in the presence or absence of Y-PP and then incu-
bated with a[ 32 p]GTP and either PDGF or its vehicle for a fur-
ther 3 min. Values for the total 132pl content of Rac-1(EE) are
given and are means + SEM (n=6). In an equivalent experiment
performed using an analogous unphosphorylated peptide in the
place of Y-PP, PDGF stimulated a 43 4% (n=3) increase in the
total 32p incorporated into Rac-1 (EE).
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Fig. 6. Effect of wortmannin or Y-PP on PDGF-stimulated synthe-
sis of Ptdlns(3,4,5)P3. [32P]-prelabelled PDGFRf3-PAE-49 cells
were permeabilized for 3 mins in the presence or absence of
Y-PP or wortmannin, and then incubated in the presence or
absence of PDGF for a further 1 min. Values shown are means +
range (n=2). The presence of wortmannin or Y-PP did not signifi-
cantly effect the levels of 32 P]Ptdlns4P or [32P]Ptdlns(4,5)P2
measured in the same experiment.
We observe that expression of Rac-1(EE), to levels sub-
stantially greater than endogenous Rac and in the ab-
sence of PDGF or serum, leads to ruffling, membrane
localization of Rac and a high rate of basal nucleotide ex-
change on Rac-1(EE). This suggests that the presence of
'free-Rac' - caused by the overexpression of Rac relative
to endogenous RhoGDI - leads to activation of Rac.
Thus, the dissociation of the RhoGDI-Rac complex,
rather than a direct activation of a putative Rac-
GEX, may be the key step in the activation of Rac. But
wortmannin prevents PDGF-stimulated nucleotide ex-
change on Rac-I(EE) and hence the putative dissociation
of the RhoGDI-Rac complex, so why do we still see a
PDGF-dependent inhibition of Rac-GTP hydrolysis in
the presence of wortmannin? We suggest the explanation
lies in the fact that, due to the overexpression of Rac-
1(EE) there is free Rac-l(EE)-GTP in the cells, and it is
the inhibition of GTP hydrolysis in this component that
we observe. Clearly, this hypothesis can be tested by intro-
ducing exogenous RhoGDI into PDGFR-PAE-49 cells.
The magnitude of the GTP-Rac loading response we
observe is small - 1.7-times control levels in the 'intact
cell' experiments - and, furthermore, this response is
observed in cells expressing an epitope-tagged Rac at
levels approximately 10-fold greater than its endogenous
counterpart. Overexpression of Rac(EE) at these levels,
it could be argued, may be sufficiently 'unphysiological'
to generate experimental artifacts. However, these obser-
vations should be held in the context of similar data
assessing the agonist-dependent activation of Ras.
Fig. 7. Possible mechanisms for Rac-regulation by the PDGF receptor. (a) Model based on analogy with the proposed regulation of Rab
proteins. Rab proteins are relatives of Ras that can cycle between an an inactive, GDP-bound state in the cytosol and a GTP-bound state
attached to specific membranes. Cytosolic Rab proteins appear to be complexed to a Rab-GDI, which inhibits their nucleotide exchange
and is involved in the process of correct delivery of the Rab to its target membranes. Only subsequently, once the Rab proteins are mem-
brane associated, do they interact with Rab-GEXs [54-561. In this model, the primary point of regulation is the splitting of the RhoGDI-Rac
complex, and guanine nucleotide exchange occurs subsequently (this could occur in a regulated or non-regulated fashion and may even
rely on the intrinsic guanine nucleotide exchange rate of free Rac). (b) Model based on analogy with the regulation of heterotrimeric G pro-
teins. The core, GTP binding and hydrolyzing u subunits of heterotrimeric G-proteins appear to contain a helical subdomain which serves
the role of a GDI [57,58]. Activated cell surface receptors can bind to the basal state, GDP-bound (x3y complex in a manner that breaks the
GDI-like helical domain's block on guanine nucleotide exchange [56], hence enabling exchange of bound GDP for GTP and transition to
an active conformation. The activated receptor can thus be thought of as a guanine nucleotide exchanger, and the removal of GDI-like
inhibition and activation of guanine nucleotide exchange are essentially synchronous.
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It is now clear, from the large number of studies addres-
sing this issue, that there is substantial variation between
different cell types responding to a single agonist, and
between different agonists acting on the same cells, in
their ability to stimulate accumulation of GTP-Ras. For
example, PDGF has been reported to stimulate 1.5-8.0-
fold increases in cellular GTP-Ras levels [27,41-43].
This variation probably results from a combination of the
distinct pathways by which receptors can regulate the
activation of Ras, and the differential expression of these
pathways, or their differential sensitivity to receptors [44].
Interestingly, though, substantial overexpression of wild-
type Ras proteins (-30 fold over endogenous levels),
does not significantly alter the ability of a given agonist
to stimulate Ras-activation [43].
Even in those situations where the level of receptor-
stimulated Ras activation is low - in PDGF-stimulated
3T3 cells, for example - Ras is known, on the basis of
experiments using N17 Ras and Ras-neutralizing anti-
bodies, to play a critical role in agonist-stimulated mito-
genesis [45] or the activation of the MAP-kinase sig-
nalling pathway [46]. This suggests these apparently small
changes in the GTP-Ras:GDP-Ras ratio are physiologi-
cally relevant. There are several possible reasons for this:
the assays of Ras-activation may underestimate the scale
of the response in vivo; Ras effectors may be highly sensi-
tive to changes in the GTP-Ras:GDP-Ras balance in
cells; or only a small proportion of total cellular Ras may
be relevant to the receptor pathways under consideration.
Clearly, these factors suggest that the PDGF-stimulated
increase in GTP-bound Rac that we report may be phys-
iologically significant. Furthermore, several additional
features, of both the regulation of Rac and the assays we
adopt, indicate that it is possible we may be significantly
underestimating - relative to similar estimates of Ras-
activation - the extent of activation of Rac in vivo.
Thus, the presence in cells of RhoGDI, the ability to
bind to GDP-Rac of which may be competitively inhib-
ited by the overexpression of epitope-tagged Rac (see
above), and the fact that our epitope-tag-directed anti-
bodies do not neutralize Rac-GTPase activity, could
both result in a loss of measurable signal.
A number of independent experimental strategies all
point to a critical involvement of the PI 3-kinase-cat-
alyzed production of Ptdlns(3,4,5)-P 3 in the PDGF stim-
ulated activation of Rac. V12 Rac can stimulate ruffling
in the presence of either wortmannin or Ap85; wort-
mannin inhibits a PDGF-stimulated increase in the GTP
content of Rac in vivo; and, in permeabilized cells, wort-
mannin and Y-PP inhibit PDGF-stimulated guanine
nucleotide exchange on Rac. Wortmannin does not sub-
stantially inhibit PDGF-stimulated P-receptor autophos-
phorylation, general tyrosine phosphorylation of cell
substrates or inositol phosphate production in PDGFR3-
PAE cells [6]. Other workers have shown that wortmannin
does not inhibit an insulin-stimulated increase in the GTP-
content of Ras [10]. Thus, it is likely that wortmannin can
be used as a relatively selective tool to inhibit the hor-
mone-stimulated synthesis of Ptdlns(3,4,5)-P 3. In per-
meabilized cells, the Y-PP peptide inhibits, in parallel,
both the PDGF-stimulated synthesis of Ptdlns(3,4,5)-P 3
and guanine-nucleotide exchange on Rac, whereas ana-
logous peptides are without effect on PDGF-stimulated
guanine-nucleotide exchange on Ras, in essentially
identical assays [47]. Taken together, these observations
provide a very strong argument that Ptdlns(3,4,5)-P 3, di-
rectly or indirectly, stimulates guanine-nucleotide ex-
change on Rac, and that this mechanism is critical for the
effective activation of Rac.
Recent evidence has shown that Rac-family proteins
may bind to, and activate, PI 3-kinase directly [48,49].
Taken together with the evidence reported here that PI
3-kinase activation stimulates an increase in GTP-Rac
levels, this recent data may indicate the existence of feed-
back control within the pathway from PI 3-kinase to
membrane ruffling. This is reminiscent of the reported
feedback effects of calcium ions on the activity of phos-
phoinositidase C that have been observed in some cell
types, and that have caused so much confusion in the
process of defining the flow of events leading from phos-
phoinositidase C, via Ins(1,4,5)-P 3, to the mobilization
of calcium from intracellular stores.
Conclusions
The precise biochemical consequences of Rac activation
are still poorly understood, but they are likely to involve
direct Rac-activation of specific protein kinases [50]. It is
easy to envisage, therefore, that Rac might adopt the role
of a ubiquitous effector of the PI 3-kinase/Ptdlns(3,4,5)-
P3 signalling pathway [6]. Some evidence for the in-
volvement of Rac in certain. specialized cell responses
that are thought to depend upon PI 3-kinase activation
has already been presented - for example, the involve-
ment of Rac in the function of the neutrophil oxidase
complex [51]. Our results suggest that Rac, or related
small molecular weight G proteins, may also be involved
in other cell responses, such as in the control of glucose
transport, activation of pp70 S6 kinase and the control of
neurite outgrowth.
Materials and methods
Materials
Radiolabelled inorganic phosphate ([32p]Pi) and aX[ 32P]GTP
were obtained from Amersham International. Anti-Rac-1
peptide rabbit polyclonal antiserum, anti-EE and anti-myc
mouse monoclonal antibodies were from ONYX (San Fran-
cisco). Protein G- and protein A-sepharose beads were from
Pharmacia. Human recombinant PDGF-BB was from Calbio-
chem. Fluorescein isothiocyanate (FITC)-phalloidin, GTP,
GDP and wortmannin were from Sigma. Complementary
DNAs for human Rac-1, N17 Rac-l and V12 Rac-l were
gifts from A. Hall (University College, London). Ham's F12
medium and phosphate-free EMEM were from GIBCO and
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ICN, respectively. Polyethyleneimine cellulose plates (cPoly-
gram Cel 300 PEI, 20 x 20 cm) were from CamLab (England).
Nitrocellulose filters were from Schleicher and Schuell.
Measurement of lamellipodia formation in PDGFRP-PAE
cells injected with N17 Rac-1 and V12 Rac-1
Myc epitope-tagged cDNAs of N17 Rac-1 and V12 Rac-1
were cloned into the mammalian expression vector EXV3.
PDGFRP-PAE and Y740/751F-PDGFR3-PAE cells were
grown on coverslips in Ham's F12 containing 10 % FBS. The
various expression plasmids were microinjected into the nu-
cleus: V12 Rac-1 at 50 lg ml-1; N17 Rac-1 and Ap85 at
100 plg ml-1. The injected cells were serum starved for 12 hrs
in a 1:1 mixture of DMEM:Ham's F12 medium supple-
mented with 0.1 % fatty-acid-free BSA; challenged with wort-
mannin (Sigma, 200 ng ml- l) or DMSO (0.2 %) for 10 mins,
and subsequently with PDGF-BB (50 ng ml-') for 2 mins.
The cells were fixed and processed for FITC-phalloidin and
Myc immunofluorescence, as described previously [52].
Derivation of PDGFR[-PAE cells expressing Rac- 1 (EE)
Rac-1 was tagged at the amino terminus with an EE-epitope
of sequence MEFMPM (single letter amino-acid code) [28].
The cDNA encoding this hybrid protein was inserted down-
stream of a strong CMV1E1 promoter [6] in a mammalian ex-
pression vector conferring hygromycin resistance. Wild-type
PDGFR3-PAE cells were transfected with this vector (using
the calcium phosphate precipitation method) and stable clones
expressing Rac-1 (EE) were selected and maintained in Ham's
F12 medium containing 10 % FBS and 60 plg ml- hygro-
mycin. Unless indicated otherwise, the clone expressing the
lowest amount Rac-l(EE) - PDGFRI3-PAE-49 - was used
for further study.
Measurement of the [3 2 P]guanine nucleotide content of
Rac- 1(EE) in intact PDGFRP-PAE-49 cells
PDGFRI3-PAE-49 cells were seeded onto 9 cm petri dishes
(1 x 105 cells ml-', 10 ml per dish) and grown for 3 days in
Ham's F12 medium containing 10 % FBS and 60 Rlg m-1
hygromycin. The cells were serum starved and labelled with
[32p]p i for 16 hr in 5 ml (per petri dish) phosphate-free
EMEM (containing 2 mM glutamine, 0.1 % (w/v) fatty-
acid-free BSA; 40 plCi ml-1 [32p]Pi). The cells were washed
at 25 C with 5 ml of a Hepes-buffered salts solution (1.8 mM
CaC12, 5.37 mM KC1, 0.81 mM MgSO4 , 112.5 mM NaCl,
25.0 mM glucose, 25.0 mM Hepes-NaOH, 1 mM NaHCO 3,
0.1 % (w/v) fatty-acid-free BSA; pH 7.4 at 25 C) and then
warmed to 37 C over 10 mins in this solution in the presence
or absence of 120 nM wortmannin (5 ml per petri dish).
Cells were then challenged at 37 C with either PDGF-BB
(100 ng ml-l; added as a prewarmed aliquot of 1 ml per petri
dish) or its vehicle. After a further 5 mins at 37 C, the me-
dium was removed by aspiration and replaced with (0.8 ml per
petri dish) ice-cold lysis buffer (65 mM Hepes-KOH, 1.3 %
Triton X-100, 130 mM NaC1, 6.5 mM MgC12 , 1.2 mM
DTT, 0.13 mM GTP; pH 7.5 at 0 C). The petri dishes were
rocked and scraped on an ice-cold metal plate for a period of
10 min, the cell lysates were transferred to eppendorf tubes and
centrifuged (11 000 rpm, 3 mins, 0 C).
A 0.8 ml aliquot of the supernatant was removed and mixed
with 40 pl of SDS/deoxycholate (0.125% SDS, 12.5%
deoxycholate); 160 l1 2.5 M NaCl; and 80 ,ul 'pre-clear' beads
(a 50 % slurry of protein A-sepharose saturated with mouse
IgG and pre-equilibrated in lysis buffer containing 1 % BSA).
The samples were packed in ice and mixed by end-over-end
rotation for 5 min; the beads were then pelleted at 0 C and a
0.9 ml aliquot of the supernatant removed into tubes contain-
ing 30 l1 (packed volume) of EE-coupled beads (protein
G-sepharose saturated with covalently-coupled mouse anti-EE
antibody and equilibrated in lysis buffer containing 1 % BSA).
The samples were packed in ice and mixed by end-over-end
rotation for 30 mins, after which the beads were pelleted and
washed four times with ml of ice-cold 50 mM Hepes-KOH,
5 mM MgC12, 500 mM NaCI, 0.1 % Triton X-100, 0.005 %
SDS, pH 7.5 at 0 C; and then once with 1 ml of ice-cold
10 mM Hepes-KOH, 1 mM MgCl2, pH 7.5 at 0 C. The total
time taken for the procedure to this point was approximately
90 mins. Compounds labelled with [32 P]-were eluted from the
beads by the addition of 100 p. 2 M formic acid, 50 M GTP
and 50 lM GDP.
Samples were incubated for 5 mins on ice, freeze-dried, redis-
solved in 50 mM NaPO 4/ 10 mM NaP20 7 pH 7.0 (2-4 l per
sample), spotted onto PEI cellulose plates and developed in
1 M NaH 2PO4. At least 95 % of authentic (x[32 P]GTP re-
mained as [3 2P]GTP if it was added to the formic acid mixture
and taken through the above procedure. The positions of GDP
and GTP spots were identified by use of standards and their
[32P]-contents quantified with a phosphoimager (Molecular
Dynamics). If control antibody-coupled beads were used in the
final immunoprecipitation, 0.2 % of the [32P]GDP and 8 % of
the [32 P]GTP measured with the EE-coupled beads could be
detected in the appropriate spots on the final TLC separation.
Measurement of the [3 2 P]guanine nucleotide content of
Rac- 1 (EE) in permeabilized PDGFR[-PAE-49 cells
PDGFRI3-PAE-49 cells were seeded onto 35 mm petri dishes
(1 105 ml-l; 2 ml per dish) and grown for 2 days in Ham's
F12 medium containing 10 % FBS, 60 g ml- 1 hygromycin
and then serum-starved for 16 hrs in Ham's F12 medium con-
taining 0.1 % BSA. The cells were washed in situ at 25 C with
1 x 5 ml then 1 x ml of a Hepes-buffered salts solution
(25 mM Hepes-KOH, 1 mM MgCl2, 1 mM NaCl 2, 132 mM
NaC1, 0.1 % BSA; pH 7.4 at 25 C). This solution was then
removed by aspiration and the cells permeabilized at 37 C in
1 ml (per petri) of a prewarmed buffer containing streptolysin-
O (50 mM Hepes-KOH, 10 mM NaC1, 70 mM glutamate/K,
3mM MgCl2, 1.25 mM Mg-ATP, 0.29mM CaCl2, 1 mM
EGTA/K, 0.1 % BSA, 0.4 U ml- streptolysin-O; pH 7.3 at
37 C) for 2 mins. The buffer was then removed by aspiration
and replaced with an identical buffer prewarmed to 37 C con-
taining -18 plCi ml-l [3 2P]GTP and either 100 ng nml-'
PDGF or diluent.
After further incubation at 37 C for the indicated periods of
time, the medium was aspirated and replaced with 1 ml of
ice-cold lysis buffer (50 mM Hepes-KOH, 1 % Triton X-100,
0.4 M NaCl, 5 mM MgC12, 0.05 % SDS, 0.5 % deoxycholate,
0.1 mM GTP; pH 7.5 at 0 °C). The petri dishes were rocked
and scraped on an ice-cold metal plate for 10 mrins and the cell
lysates removed, centrifuged (11 000 rpm, 0 C, 3 mins) and
0.9 ml aliquots of the supernatant added directly to EE-cou-
pled beads (30 aI packed volume). The samples were then
processed precisely as described above for the 'intact cell' ex-
periments except that only three washes were performed with
the detergent-containing buffer. In some experiments aliquots
of the [32 P]GTP-containing permeabilization buffer were re-
moved, after 2-5 mins in the presence of the cells, and resolved
directly on PEI cellulose: > 95% of the [32p] migrated as
[32 P]GTP. Further, in some experiments the total radioactiity
in the lysates prior to immunoprecipitation was quantified; and
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no significant differences were found between control and
PDGF-stimulated samples.
In experiments investigating the effects of wortmannin, the
above protocol was followed, except that cells were warmed
from 25 C to 37 C over a period of 5 mins prior to perme-
abilization in the Hepes-buffered salts solution in the presence
or absence of 100 nM wortmahnin and then, where appropri-
ate, 100 nM wortmannin was included in all permeabilization
buffers. In experiments investigating the effects of Y-PP,
200 RIM Y-PP [53] (dissolved in permeabilization buffer) was
included in all permeabilization buffers and the initial period of
permeabilization -prior to the addition of PDGF (100 ng 1ml-1)
and c[ 32p]GTP (approximately 10 ICi m-1) - was increased
to 3 min.
Measurement of [32 P]PtdIns(3,4,5)-P3 synthesis in
permeabilized PDGFRP-PAE-49
PDGFR{-PAE-49 cells were grown on 35 mm petri dishes
and serum-starved for 16 hr in phosphate-free EMEM; for the
last 2 hr of this period the cells were labelled with [32p]p i
(0.2 mCi [32P]P, 1 ml per petri). The cells were then pro-
cessed as described above, for the measurement of [32p] gua-
nine nucleotides in permeabilized PDGFR3-PAE-49 cells,
except that [32P]GTP was omitted and the incubations were
terminated by removal of the medium by aspiration and the
addition of 0.5 ml ice-cold 1 M HCL. Lipid extracts were pre-
pared, and the deacylated lipid head groups resolved ansi
quantified by HPLC as described previously [4].
Measurement of the [32 P]guanine nucleotide content of
Rac-I (EE) after immunoprecipitation with anti-EE in vitro
Baculovirus expressed Rac-l(EE) was prepared and loaded
with oe[ 32 P]GTP as described previously [30]. A 200 1 aliquot
containing approximately 0.5 pmol of ot[ 32 P]GTP-loaded
Rac-I(EE), was added to 8 ml of the lysis buffer; and 0.8 ml
aliquots of this mixture were either filtered immediately
through 25 mm diameter nitrocellulose filters (defining the
'zero time' guanine nucleotide content), or immunoprecipi-
tated, in the presence or absence, of an appropriately concen-
trated wild-type PAE cell lysate (as described above, for the
'intact cell' experiments). Radiolabelled [32p] nucleotides were
eluted from the filters, or the washed beads, and resolved by
thin-layer chromatography on PEI cellulose (see above).
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